Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
CTKB
CTKB
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
CTKB News
Cytek (CTKB) Q4 2025 Earnings Call Transcript
Feb 27 2026
NASDAQ.COM
Cytek Biosciences Reports Record Q4 2025 Revenue and Growth Outlook
Feb 27 2026
seekingalpha
Cytek Biosciences Q4 Earnings Report Analysis
Feb 26 2026
seekingalpha
Cytek Biosciences (CTKB) Projects $201 Million Revenue for 2025 with Q4 Growth of 8%
Jan 12 2026
NASDAQ.COM
Cytek Biosciences Reports $201 Million Revenue for 2025, Q4 Growth of 8%
Jan 12 2026
Globenewswire
Cytek Biosciences Reports $201 Million Revenue for 2025, Q4 Growth of 8%
Jan 12 2026
Newsfilter
Major Stocks Including Legence, Cidara Therapeutics, Avadel Pharmaceuticals, and Omeros Rise on Friday
Nov 14 2025
Benzinga
TIME Names Cytek® Biosciences Among America's Growth Leaders for 2026
Nov 12 2025
Newsfilter
Medtech Stocks Surge in After-Hours Trading: RxSight, Penumbra, and Evolus Take the Lead
Nov 06 2025
NASDAQ.COM
Cytek® Biosciences Strengthens Efforts to Enhance Flow Cytometry Accessibility
Oct 29 2025
Newsfilter
Projected 12-Month Target for SPTM by Analysts
Oct 29 2025
NASDAQ.COM
Cytek® Biosciences Enhances European Operations with New Amsterdam Facility to Improve Customer Service and Foster Growth
Oct 15 2025
Newsfilter
Alvotech (ALVO) Rises 8.6%: Could This Signal More Upside Ahead?
Sep 24 2025
NASDAQ.COM
Cytek Biosciences Introduces Comprehensive Cell Analysis at Major Global Conferences ICCS and ESCCA
Sep 10 2025
Newsfilter
Insider Purchase: Chief Financial Officer of $CTKB Buys 35,000 Shares
Jun 03 2025
NASDAQ.COM
Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer
May 29 2025
Newsfilter
Show More News
